ArticleNanomedicine : nanotechnology, biology, and medicine2025

Two-component T-cell immunotherapy enables antigen pre-targeting to reduce cytokine release without forfeiting efficacy.

M Tommy Gambles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.